Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Launoy

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Bulletin Du Cancer|February 19, 2019
[Impact of the integration of FIT in the colorectal cancer screening program in France]Guy Launoy
La Revue Du Praticien|March 16, 2010
[Epidemiology of cancers in France]Guy Launoy,
Sante Publique (Vandoeuvre-Les-Nancy, France)|June 20, 2022
Célia Berchi, Guy Launoy
Bulletin Du Cancer|November 4, 2005
[Advantage of immunochemical fecal occult blood test in screening for colorectal cancer]Guy Launoy, C Berchi
Sante Publique (Vandoeuvre-Les-Nancy, France)|May 7, 2020
[Participation in organized screening for bowel cancer and screening for prostate cancer]Célia Berchi, Guy Launoy
La Revue Du Praticien|August 25, 2015
[Epidemiology of colorectal cancer]Anne-Marie Bouvier, Guy Launoy
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 14, 2006
The reasons of general practitioners for promoting colorectal cancer mass screening in FranceCélia Berchi, Jean-Marc Dupuis, Guy Launoy
Cancers|September 10, 2021
Socio-Territorial Inequities in the French National Breast Cancer Screening Programme-A Cross-Sectional Multilevel StudyQuentin Rollet, Élodie Guillaume, Ludivine Launay, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|September 14, 2022
Maud Charvin, Grégoire Moutel, Guy Launoy, et al.
International Journal of Technology Assessment in Health Care|January 12, 2010
Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screeningCélia Berchi, Lydia Guittet, Véronique Bouvier, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Bulletin Du Cancer|February 19, 2019
[Impact of the integration of FIT in the colorectal cancer screening program in France]Guy Launoy
La Revue Du Praticien|March 16, 2010
[Epidemiology of cancers in France]Guy Launoy,
Sante Publique (Vandoeuvre-Les-Nancy, France)|June 20, 2022
Célia Berchi, Guy Launoy
Bulletin Du Cancer|November 4, 2005
[Advantage of immunochemical fecal occult blood test in screening for colorectal cancer]Guy Launoy, C Berchi
Sante Publique (Vandoeuvre-Les-Nancy, France)|May 7, 2020
[Participation in organized screening for bowel cancer and screening for prostate cancer]Célia Berchi, Guy Launoy
La Revue Du Praticien|August 25, 2015
[Epidemiology of colorectal cancer]Anne-Marie Bouvier, Guy Launoy
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 14, 2006
The reasons of general practitioners for promoting colorectal cancer mass screening in FranceCélia Berchi, Jean-Marc Dupuis, Guy Launoy
Cancers|September 10, 2021
Socio-Territorial Inequities in the French National Breast Cancer Screening Programme-A Cross-Sectional Multilevel StudyQuentin Rollet, Élodie Guillaume, Ludivine Launay, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|September 14, 2022
Maud Charvin, Grégoire Moutel, Guy Launoy, et al.
International Journal of Technology Assessment in Health Care|January 12, 2010
Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screeningCélia Berchi, Lydia Guittet, Véronique Bouvier, et al.
Pageof 15